James D. Douketis
Expertise in
8
conditions

James D. Douketis

Hamilton, ON, CA 
Expertise in
8
conditions
Hamilton, ON, CA 
OverviewLocationsClinical Research

Overview

James Douketis practices in Hamilton, Canada. Douketis is highly rated in 8 conditions, according to our data. Their top areas of expertise are Venous Thromboembolism (VTE), Deep Vein Thrombosis, Mesenteric Venous Thrombosis, Thrombectomy, and Hormone Replacement Therapy (HRT).

Their clinical research consists of co-authoring 270 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Hamilton, ON, Canada
Other Locations
St Joseph's Hospital, Canada
Montreal, QC, Canada
Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Management and Outcomes of Patients Receiving Oral Anticoagulants Who Require an Urgent/Emergency Surgery or Procedure: A Prospective Registry Study
Management and Outcomes of Patients Receiving Oral Anticoagulants Who Require an Urgent/Emergency Surgery or Procedure: A Prospective Registry Study
Enrollment Status: Completed
Publish Date: May 01, 2023
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Perioperative Anticoagulant Use (Dabigatran, Rivaroxaban, or Apixaban) for Elective Surgery/Procedure Evaluation in Patients With Atrial Fibrillation (AF).
Enrollment Status: Completed
Publish Date: June 28, 2019
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Extended Low-Molecular Weight Heparin VTE Prophylaxis in the Thoracic Surgery Population, a Prospective, Randomized Controlled Study
Enrollment Status: Completed
Publish Date: September 18, 2018
Intervention Type: Drug, Other
Study Phase: Phase 1/Phase 2
View 2 Less Clinical Trials

270 Total Publications

In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
In survivors of ICH with AF, DOACs reduced incident ischemic stroke and increased recurrent ICH at a median 1.4 y.
Journal: Annals of internal medicine
Published: June 02, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Douketis's expertise for a condition
ConditionClose
View All 21 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile